USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN
Yıl: 2020 Cilt: 20 Sayı: 3 Sayfa Aralığı: 553 - 566 Metin Dili: İngilizce DOI: 10.5505/amj.2020.86648 İndeks Tarihi: 06-10-2020
USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN
Öz: Objectives: Musculoskeletal disorders are a group of disorders that affect the joints, bones, and muscles, causing long-term disability. The aim of the present study was to examine the usefulness of herbal products in musculoskeletal system pain.Materials and Methods: This descriptive sectional study included 98 individuals who applied to Outpatient Clinic with chronic musculoskeletal system pain, who were 18 years old and over, who had reported using herbal products for more than a week and who were willing to participate in the study. The individuals were subjected to a 26-item questionnaire form which was prepared by the authors and which questioned sociodemographic characteristics of the participants and their use of herbal products.Results: It was found that 7.09% of the individuals with musculoskeletal system pain used herbal products. The most common six products used by the individuals in decreasing order were horse chestnut gel (19.38%), olive oil (15.30%), okra seed (13.26%), plane tree leaves (10.20%), juniper oil (8.16%) and black cumin oil (7.14%). Of all individuals, 57.14% of them (n = 56) reported that they did not need to notify physicians about their herbal product use.Conclusion: It is clear that patients resort to the use of herbal products in musculoskeletal system pain. In order to have better outcomes with the herbal products used in therapy, patients should be informed about the proper dose, duration, indication and time, and side effects and drug interactions of herbal products. Patients should be encouraged about informing their physicians and healthcare providers about their use of herbal products.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
- 2. Banerjee A, Jadhav SL, Bhawalkar JS. Limitations of activities in patients with musculoskeletal disorders. Ann Med Health Sci Res 2012;2(1):5-9.
- 3. Mobasheri A. Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Current rheumatology reports 2012;14(6):604-16.
- 4. Özdemir CL, Akgün Ş. Yaşlı bireylerde ilaç kullanımı ve geleneksel uygulamalar. MN Dahili Tıp Bilim Derg 2006;1(1):27-34.
- 5. Vallerand AH, Fouladbakhsh JM, Templin T. The use of complementary/alternative medicine therapies for the self-treatment of pain among residents of urban, suburban, and rural communities. Am J Public Health 2003;93(6):923-25.
- 6. Ernst E. Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion 2000;13:4–15.
- 7. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002;23:136–9.
- 8. Weiner DK, Ernst E. Complementary and Alternative Approaches to the Treatment of Persistent Musculoskeletal Pain. Clin J Pain 2004;20(4):244–55.
- 9. Abdel-Aziz SM, Aeron A, Kahil TA: Health benefits and possible risks of herbal medicine. In: Microbes in Food and Health, Garg N. Abdel-Aziz SM. Aeron A (eds). 1st ed. Switzerland: Springer; 2016:97- 116.
- 10. Directive 2001/83/Ec of The European Parliament and of The Council Of 6 November 2001, on The Community Code Relating To Medicinal Products for Human Use Official Journal L – 311, 28/11/2004, P. 67 –128. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideli ne/2009/10/WC500004481.pdf, Erişim tarihi: 13.08.2020.
- 11. Kavadar G, Demir SE, Aytekin E, Akbal Y. Use of traditional and complementary medicine for musculoskeletal diseases. Turkish journal of medical sciences 2019;49(3):809-14.
- 12. Wetzel D, Menke W, Dieter R, Smasal V, Giannetti B, Bulitta M. Escin/diethylammonium salicylate/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med 2002;36(3):183–8.
- 13. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database of Syst Rev 2012;11(11): CD003230.
- 14. European Medicine Agency. https://www.ema.europa.eu/en/medicines/field_ema_web_categories%253Aname_field/Herbal/fiel d_ema_herb_outcome/european-union-herbal-monograph-254, Erişim tarihi: 13.08.2020.
- 15. el-Dessouki S. Aflatoxins in cosmetics containing substrates for aflatoxin-producing fungi. Food Chem Toxicol 1992;30(11):993‐4.
- 16. Phytotherapeutic Monographs (BGA,Comission E,Germany). https://buecher.heilpflanzenwelt.de/BGA-Commission-E-Monographs/, Erişim tarihi: 13.08.2020.
- 17. Bohlooli S, Jastan M, Nakhostin-Roohi B, Mohammadi S, Baghaei Z. A pilot double-blinded, randomized, clinical trial of topical virgin olive oil versus piroxicam gel in osteoarthritis of the knee. J Clin Rheumatol 2012;18(2):99-101.
- 18. Nakhostin- Roohi B, Bohlooli S. Comparison the Efficacy of Ultrasound Therapy and Phonophoresis with Virgin Olive Oil on Athletes' Chronic Low Back Pain: A Pilot Study. J Zanjan Univ Med Sci 2014;22:43–51.
- 19. Hossen MA, Jahan I, Mamun MAA, Sakir JAMS, Shamimuzzaman M, Uddin MJ, et al. CNS depressant and analgesic activities of Okra (Abelmoschus esculentus Linn.). Mol Clin Pharmacol 2013;4(1):44- 52.
- 20. Ziaei A, Sahranavard S, Faizi M. Topical herbal remedies for treatment of joint pain according to Iranian Traditional Medicine. Research Journal of Pharmacognosy 2016;3(3):63-72.
- 21. Hajhashemi V, Ghannadi A, Mousavi S. Antinociceptive study of extracts of Platanus orientalis leaves in mice. Res pharm sci 2011;6(2):123.
- 22. Saraçoğlu İA. Osteoarthritis, Gout and Antidepressant Effects of Platanus anatolius versus Platanus orientalis. Biological and Chemical Research 2018:79-84.
- 23. Moghaddam M, Ghasemi Pirbalouti A, Farhadi, N. Seasonal variation in Juniperus polycarpos var. turcomanica essential oil from northeast of Iran. J Essent Oil Res 2018;30(3):225-31.
- 24. Banerjee S, Mukherjee A, Chatterjee TK. Evaluation of analgesic activities of methanolic extract of medicinal plant Juniperus communis Linn. Int J Pharm Pharm Sci 2012;4(5):547-50.
- 25. Bais S, Abrol N, Prashar Y. Modulatory effect of standardised amentoflavone isolated from Juniperus communis L. agianst Freund’s adjuvant induced arthritis in rats (histopathological and X Ray anaysis). Biomed Pharmacother 2017;86:381-92.
- 26. Shaw D. Adverse effects of herbal remedies: the case to answer. In:The Essential Guide to Herbal Safety. Mills S, Bone K (eds). First ed., Edinburgh: Elsevier Churchill Livingstone;2005:19.
- 27. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed 2013;3(5):337–52.
- 28. Kooshki A, Forouzan R, Rakhshani MH, Mohammadi M. Effect of topical application of nigella sativa oil and oral acetaminophen on pain in elderly with knee osteoarthritis: A crossover clinical trial. Electron Physician 2016;8(11):3193-7.
- 29. Sarışen O, Çalışkan D. Fitoterapi: Bitkilerle Tedaviye Dikkat. Sted 2005;14(8):182-7.
- 30. İstanbulluoğlu S, Çeliker A. İlaç bitkisel ürün etkileşimlerinin önlenmesinde eczacının rolü. FABAD J Pharm Sci 2018;43(3):291-305.
- 31. Briggs JP. Complementary, Alternative, and Integrative Health Approaches. In: Harrison’s Principles of Internal Medicine, Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds). 15th ed. New York: McGraw-Hill; 2001:86.
- 32. Üstü Y, Keskin, A. Keten Tohumunun Tıbbi Kullanımı. Ankara Med J 2019;19(3):665-9.
- 33. Koç Z, Sağlam Z. Yaşlı hipertansif hastaların bitkisel ürün kullanım durumlarının belirlenmesi. Turk Geriatri Derg 2012;15:83-4.
- 34. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010;55(6):515-25.
- 35. Efe D, Akça NK, Kiper S, Aydın G, Gümüş, K. Supportive methods used by the individuals with hypertension to decrease blood pressure. Spatula DD 2012;2(4):207-12.
| APA | OKAN S, OKAN F (2020). USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. , 553 - 566. 10.5505/amj.2020.86648 |
| Chicago | OKAN SEVİL,OKAN FATİH USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. (2020): 553 - 566. 10.5505/amj.2020.86648 |
| MLA | OKAN SEVİL,OKAN FATİH USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. , 2020, ss.553 - 566. 10.5505/amj.2020.86648 |
| AMA | OKAN S,OKAN F USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. . 2020; 553 - 566. 10.5505/amj.2020.86648 |
| Vancouver | OKAN S,OKAN F USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. . 2020; 553 - 566. 10.5505/amj.2020.86648 |
| IEEE | OKAN S,OKAN F "USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN." , ss.553 - 566, 2020. 10.5505/amj.2020.86648 |
| ISNAD | OKAN, SEVİL - OKAN, FATİH. "USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN". (2020), 553-566. https://doi.org/10.5505/amj.2020.86648 |
| APA | OKAN S, OKAN F (2020). USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. Ankara Medical Journal, 20(3), 553 - 566. 10.5505/amj.2020.86648 |
| Chicago | OKAN SEVİL,OKAN FATİH USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. Ankara Medical Journal 20, no.3 (2020): 553 - 566. 10.5505/amj.2020.86648 |
| MLA | OKAN SEVİL,OKAN FATİH USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. Ankara Medical Journal, vol.20, no.3, 2020, ss.553 - 566. 10.5505/amj.2020.86648 |
| AMA | OKAN S,OKAN F USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. Ankara Medical Journal. 2020; 20(3): 553 - 566. 10.5505/amj.2020.86648 |
| Vancouver | OKAN S,OKAN F USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN. Ankara Medical Journal. 2020; 20(3): 553 - 566. 10.5505/amj.2020.86648 |
| IEEE | OKAN S,OKAN F "USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN." Ankara Medical Journal, 20, ss.553 - 566, 2020. 10.5505/amj.2020.86648 |
| ISNAD | OKAN, SEVİL - OKAN, FATİH. "USE OF HERBAL PRODUCTS IN MUSCULOSKELETAL SYSTEM PAIN". Ankara Medical Journal 20/3 (2020), 553-566. https://doi.org/10.5505/amj.2020.86648 |
